Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Carcinoma, Non-Small-Cell Lung 29Carcinoma, Transitional Cell 25Urinary Bladder Neoplasms 24Neoplasms 22Carcinoma, Merkel Cell 20Neoplasm Metastasis 18Carcinoma, Renal Cell 17Colorectal Neoplasms 16Breast Neoplasms 16Squamous Cell Carcinoma of Head and Neck 15Ovarian Neoplasms 14Triple Negative Breast Neoplasms 11Pancreatic Neoplasms 9Melanoma 9Head and Neck Neoplasms 8Stomach Neoplasms 7Recurrence 6Carcinoma, Hepatocellular 6Ureteral Neoplasms 5Small Cell Lung Carcinoma 5Prostatic Neoplasms 5Urethral Neoplasms 4Sarcoma 4Neuroendocrine Tumors 4Leukemia, Myeloid, Acute 4Glioblastoma 4Carcinoma, Squamous Cell 4Uterine Cervical Neoplasms 3Turcot syndrome 3Skin Neoplasms 3

Interventions

avelumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × PD-L1 Positive Mutation Tumor × avelumab × Clear all
NCT03491345 2022-08-09

K-Basket, Avelumab, Biomarker-driven, Advanced Solid Tumor

Yonsei University

Phase 2 Unknown
60 enrolled
Other solid neoplasm

PD-L1 Positive Mutation Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡